Literature DB >> 16273081

MTH1, an oxidized purine nucleoside triphosphatase, protects the dopamine neurons from oxidative damage in nucleic acids caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

H Yamaguchi1, K Kajitani, Y Dan, M Furuichi, M Ohno, K Sakumi, D Kang, Y Nakabeppu.   

Abstract

We previously reported that 8-oxoguanine (8-oxoG) accumulates in the cytoplasm of dopamine neurons in the substantia nigra of patients with Parkinson's disease and the expression of MTH1 carrying an oxidized purine nucleoside triphosphatase activity increases in these neurons, thus suggesting that oxidative damage in nucleic acids is involved in dopamine neuron loss. In the present study, we found that levels of 8-oxoG in cellular DNA and RNA increased in the mouse nigrostriatal system during the tyrosine hydroxylase (TH)-positive dopamine neuron loss induced by the administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). MTH1-null mice exhibited a greater accumulation of 8-oxoG in mitochondrial DNA accompanied by a more significant decrease in TH and dopamine transporter immunoreactivities in the striatum after MPTP administration, than in wild-type mice. We thus demonstrated that MTH1 protects the dopamine neurons from oxidative damage in the nucleic acids, especially in the mitochondrial DNA of striatal nerve terminals of dopamine neurons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16273081     DOI: 10.1038/sj.cdd.4401788

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  36 in total

Review 1.  Oxidative damage to RNA in aging and neurodegenerative disorders.

Authors:  Akihiko Nunomura; Paula I Moreira; Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

Review 2.  Mitochondrial DNA damage and its consequences for mitochondrial gene expression.

Authors:  Susan D Cline
Journal:  Biochim Biophys Acta       Date:  2012-06-19

3.  Birth of MTH1 as a therapeutic target for glioblastoma: MTH1 is indispensable for gliomatumorigenesis.

Authors:  Yanyang Tu; Zhen Wang; Xin Wang; Hongwei Yang; Pengxing Zhang; Mark Johnson; Nan Liu; Hui Liu; Weilin Jin; Yongsheng Zhang; Daxiang Cui
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

4.  The DNA polymerase gamma Y955C disease variant associated with PEO and parkinsonism mediates the incorporation and translesion synthesis opposite 7,8-dihydro-8-oxo-2'-deoxyguanosine.

Authors:  Maria A Graziewicz; Rachelle J Bienstock; William C Copeland
Journal:  Hum Mol Genet       Date:  2007-08-27       Impact factor: 6.150

5.  8-Oxoguanine causes neurodegeneration during MUTYH-mediated DNA base excision repair.

Authors:  Zijing Sheng; Sugako Oka; Daisuke Tsuchimoto; Nona Abolhassani; Hiroko Nomaru; Kunihiko Sakumi; Hidetaka Yamada; Yusaku Nakabeppu
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

6.  Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease.

Authors:  Laurie H Sanders; Jennifer McCoy; Xiaoping Hu; Pier G Mastroberardino; Bryan C Dickinson; Christopher J Chang; Charleen T Chu; Bennett Van Houten; J T Greenamyre
Journal:  Neurobiol Dis       Date:  2014-06-27       Impact factor: 5.996

7.  Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia.

Authors:  Serafí Cambray; Manuel Portero-Otin; Mariona Jové; Nuria Torreguitart; Laura Colàs-Campàs; Arabela Sanz; Ikram Benabdelhak; Muge Yemisci; Turgay Dalkara; Buket Dönmez-Demir; Joaquim Egea; Francisco Purroy
Journal:  Mol Neurobiol       Date:  2017-12-21       Impact factor: 5.590

8.  MUTYH promotes oxidative microglial activation and inherited retinal degeneration.

Authors:  Shunji Nakatake; Yusuke Murakami; Yasuhiro Ikeda; Noriko Morioka; Takashi Tachibana; Kohta Fujiwara; Noriko Yoshida; Shoji Notomi; Toshio Hisatomi; Shigeo Yoshida; Tatsuro Ishibashi; Yusaku Nakabeppu; Koh-Hei Sonoda
Journal:  JCI Insight       Date:  2016-09-22

9.  Sublethal RNA oxidation as a mechanism for neurodegenerative disease.

Authors:  Rudy J Castellani; Akihiko Nunomura; Raj K Rolston; Paula I Moreira; Atsushi Takeda; George Perry; Mark A Smith
Journal:  Int J Mol Sci       Date:  2008-05-20       Impact factor: 6.208

10.  Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  Kyota Fujita; Toshihiro Seike; Noriko Yutsudo; Mizuki Ohno; Hidetaka Yamada; Hiroo Yamaguchi; Kunihiko Sakumi; Yukiko Yamakawa; Mizuho A Kido; Atsushi Takaki; Toshihiko Katafuchi; Yoshinori Tanaka; Yusaku Nakabeppu; Mami Noda
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.